Sie suchten nach: ciklooksigenaze (Kroatisch - Englisch)

glavni je način djelovanja inhibicija ciklooksigenaze (cox).
the principal mode of action is inhibition of cyclooxygenase (cox).

ibuprofen je neselektivni inhibitor ciklooksigenaze, s posljedičnom inhibicijom sinteze prostaglandina.
ibuprofen is a non selective inhibitor of cyclo- oxygenase, leading to reduced synthesis of prostaglandins.

moćan je i selektivni inhibitor enzima ciklooksigenaze 2 (cox-2).
it is a potent and selective inhibitor of the cyclooxygenase 2 enzyme (cox-2).

valdekoksib je selektivni inhibitor ciklooksigenaze-2 (cox-2) unutar kliničkog raspona doza.
valdecoxib is a selective cyclooxygenase-2 (cox-2) inhibitor within the clinical dose range.

amfenak inhibira djelovanje prostaglandin h sintaze (ciklooksigenaze), enzima koji je potreban za stvaranje prostaglandina.
amfenac inhibits the action of prostaglandin h synthase (cyclooxygenase), an enzyme required for prostaglandin production.

pripada skupini lijekova koji se zovu cox-2 inhibitori (skraćenica za inhibitore ciklooksigenaze-2).
it is one of a family of medicines called cox-2 inhibitors (this is short for cyclo-oxygenase-2 inhibitors).

također, in vitro je dokazano da visoke doze nsail (inhibitora ciklooksigenaze) mogu zaustaviti djelovanje liposomalnog mifamurtida na aktivaciju makrofaga.
also, it has been demonstrated in vitro that high-dose nsaids (cyclooxygenase inhibitors) can block the macrophage activating effect of liposomal mifamurtide.

acetilsalicilatna kiselina (ask) inhibira agregaciju trombocita ireverzibilnom inhibicijom enzima prostaglandin ciklooksigenaze, čime sprječava stvaranje tromboksana a2, koji potiče agregaciju trombocita i vazokonstrikciju.
acetylsalicylic acid inhibits platelet aggregation by irreversible inhibition of prostaglandin cyclo-oxygenase and thus inhibits the generation of thromboxane a2, an inducer of platelet aggregation and vasoconstriction.

bolesnici koji su imali bronhospazam, akutni rinitis, nosne polipe, angioneurotski edem, urtikariju ili druge reakcije alergijskog tipa nakon uzimanja acetilsalicilne kiseline ili nesteroidnih protuupalnih lijekova (nsaid), uključujući i inhibitore cox-2 (ciklooksigenaze-2).
patients who have experienced bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria or other allergic-type reactions after taking acetylsalicylic acid or nsaids including cox-2 (cyclooxygenase-2) inhibitors.